-
1
-
-
5144231704
-
Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival
-
Rosen DG, Wang L, Jain AN, et al. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival. Clin Cancer Res. 2004;10: 6559-6566.
-
(2004)
Clin Cancer Res.
, vol.10
, pp. 6559-6566
-
-
Rosen, D.G.1
Wang, L.2
Jain, A.N.3
-
2
-
-
78650842745
-
MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer
-
Chen Y, Zaman MS, Deng G, et al. MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prev Res (Phila). 2011;4:76-86.
-
(2011)
Cancer Prev Res (Phila).
, vol.4
, pp. 76-86
-
-
Chen, Y.1
Zaman, M.S.2
Deng, G.3
-
3
-
-
84864321127
-
Aplasia Ras homolog member i is downregulated in gastric cancer and silencing its expression promotes cell growth in vitro
-
Tang HL, Hu YQ, Qin XP, et al. Aplasia Ras homolog member I is downregulated in gastric cancer and silencing its expression promotes cell growth in vitro. J Gastroenterol Hepatol. 2012;27:1395-1404.
-
(2012)
J Gastroenterol Hepatol.
, vol.27
, pp. 1395-1404
-
-
Tang, H.L.1
Hu, Y.Q.2
Qin, X.P.3
-
4
-
-
41149093072
-
Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation
-
Feng W, Marquez RT, et al. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Cancer. 2008;112:1489-1502.
-
(2008)
Cancer
, vol.112
, pp. 1489-1502
-
-
Feng, W.1
Marquez, R.T.2
-
5
-
-
0037354548
-
Epigenetic regulation of ARHI in breast and ovarian cancer cells
-
Yu Y, Fujii S, Yuan J, et al. Epigenetic regulation of ARHI in breast and ovarian cancer cells. Ann N Y Acad Sci. 2003; 983:268-277.
-
(2003)
Ann N y Acad Sci.
, vol.983
, pp. 268-277
-
-
Yu, Y.1
Fujii, S.2
Yuan, J.3
-
6
-
-
84878171024
-
STAT3 acetylation-induced promoter methylation is associated with downregulation of the ARHI tumor-suppressor gene in ovarian cancer
-
Li J, Cui G, Sun L, et al. STAT3 acetylation-induced promoter methylation is associated with downregulation of the ARHI tumor-suppressor gene in ovarian cancer. Oncol Rep. 2013;30:165-170.
-
(2013)
Oncol Rep.
, vol.30
, pp. 165-170
-
-
Li, J.1
Cui, G.2
Sun, L.3
-
7
-
-
84875980902
-
Effect of histone deacetylase inhibitors on cell apoptosis and expression of the tumor suppressor genes RUNX3 and ARHI in ovarian tumors
-
Zhang L, Liu P, Li H, et al. Effect of histone deacetylase inhibitors on cell apoptosis and expression of the tumor suppressor genes RUNX3 and ARHI in ovarian tumors. Mol Med Rep. 2013;7:1705-1709.
-
(2013)
Mol Med Rep.
, vol.7
, pp. 1705-1709
-
-
Zhang, L.1
Liu, P.2
Li, H.3
-
8
-
-
33947153008
-
Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer
-
Feng W, Lu Z, Luo RZ, et al. Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer. Int J Cancer. 2007;120:1664-1668.
-
(2007)
Int J Cancer.
, vol.120
, pp. 1664-1668
-
-
Feng, W.1
Lu, Z.2
Luo, R.Z.3
-
9
-
-
33744528546
-
Biochemistry and biology of ARHI (DIRAS3), an imprinted tumor suppressor gene whose expression is lost in ovarian and breast cancers
-
Yu Y, Luo R, Lu Z, et al. Biochemistry and biology of ARHI (DIRAS3), an imprinted tumor suppressor gene whose expression is lost in ovarian and breast cancers. Methods Enzymol. 2006;407:455-468.
-
(2006)
Methods Enzymol.
, vol.407
, pp. 455-468
-
-
Yu, Y.1
Luo, R.2
Lu, Z.3
-
10
-
-
33646411738
-
Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer
-
Lu Z, Luo RZ, Peng H, et al. Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer. Clin Cancer Res. 2006;12:2404-2413.
-
(2006)
Clin Cancer Res.
, vol.12
, pp. 2404-2413
-
-
Lu, Z.1
Luo, R.Z.2
Peng, H.3
-
11
-
-
84878795911
-
The tumor suppressor gene ARHI (DIRAS3) inhibits ovarian cancer cell migration through multiple mechanisms
-
Lu Z, Bast RC Jr. The tumor suppressor gene ARHI (DIRAS3) inhibits ovarian cancer cell migration through multiple mechanisms. Cell Adh Migr. 2013;7:232-236.
-
(2013)
Cell Adh Migr.
, vol.7
, pp. 232-236
-
-
Lu, Z.1
Bast Jr., R.C.2
-
12
-
-
10744223629
-
Reactivation of the silenced and imprinted alleles of ARHI is associated with increased histone H3 acetylation and decreased histone H3 lysine 9 methylation
-
Fujii S, Luo RZ, Yuan J, et al. Reactivation of the silenced and imprinted alleles of ARHI is associated with increased histone H3 acetylation and decreased histone H3 lysine 9 methylation. Hum Mol Genet. 2003;12:1791-1800.
-
(2003)
Hum Mol Genet.
, vol.12
, pp. 1791-1800
-
-
Fujii, S.1
Luo, R.Z.2
Yuan, J.3
-
13
-
-
0037115542
-
Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain dependent pathway
-
Bao JJ, Le XF, Wang RY, et al. Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain dependent pathway. Cancer Res. 2002;62:7264-7272.
-
(2002)
Cancer Res.
, vol.62
, pp. 7264-7272
-
-
Bao, J.J.1
Le Wang, X.F.R.Y.2
-
14
-
-
47549106474
-
Positive feedback of G1 cyclins ensures coherent cell cycle entry
-
Skotheim JM, DiTalia S, Siggia ED, et al. Positive feedback of G1 cyclins ensures coherent cell cycle entry. Nature. 2008;454:291-296.
-
(2008)
Nature
, vol.454
, pp. 291-296
-
-
Skotheim, J.M.1
Ditalia, S.2
Siggia, E.D.3
-
15
-
-
0037810249
-
Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: Potential targeting for therapeutic intervention
-
Chang F, Steelman LS, Lee JT, et al. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia. 2003;17:1263-1293.
-
(2003)
Leukemia
, vol.17
, pp. 1263-1293
-
-
Chang, F.1
Steelman, L.S.2
Lee, J.T.3
-
16
-
-
34248563290
-
The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1-to S-phase transition
-
Meloche S, Pouysségur J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1-to S-phase transition. Oncogene. 2007;26:3227-3239.
-
(2007)
Oncogene
, vol.26
, pp. 3227-3239
-
-
Meloche, S.1
Pouysségur, J.2
-
17
-
-
84864444318
-
Inhibitory effect of a Ras homologue member i on pancreatic cancer and its modulation on epithelium growth factor receptor-Ras-Raf-mitogen-activated protein kinase/extracellular regulated protein kinase/1/2 pathway
-
Lu J, Qian JM, Yang H, et al. Inhibitory effect of a Ras homologue member I on pancreatic cancer and its modulation on epithelium growth factor receptor-Ras-Raf-mitogen-activated protein kinase/extracellular regulated protein kinase/1/2 pathway. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2012;34: 197-201.
-
(2012)
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
, vol.34
, pp. 197-201
-
-
Lu, J.1
Qian, J.M.2
Yang, H.3
-
19
-
-
40149094813
-
Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells
-
Xiong H, Zhang ZG, Tian XQ, et al. Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. Neoplasia. 2008;10:287-297.
-
(2008)
Neoplasia
, vol.10
, pp. 287-297
-
-
Xiong, H.1
Zhang, Z.G.2
Tian, X.Q.3
-
20
-
-
26244463218
-
Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: Inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells
-
Lin Q, Lai R, Chirieac LR, et al. Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells. Am J Pathol. 2005;167:969-980.
-
(2005)
Am J Pathol.
, vol.167
, pp. 969-980
-
-
Lin, Q.1
Lai, R.2
Chirieac, L.R.3
-
21
-
-
84874100246
-
Expression and clinical significance of STAT3, P-STAT3, and VEGF-C in small cell lung cancer
-
Zhao X, Sun X, Li XL. Expression and Clinical Significance of STAT3, P-STAT3, and VEGF-C in small cell lung cancer. Asian Pac J Cancer Prev. 2012;13:2873-2877.
-
(2012)
Asian Pac J Cancer Prev.
, vol.13
, pp. 2873-2877
-
-
Zhao, X.1
Sun, X.2
Li, X.L.3
-
22
-
-
84855355011
-
The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways
-
Badgwell DB, Lu Z, Le K, et al. The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways. Oncogene. 2012;31:68-79.
-
(2012)
Oncogene
, vol.31
, pp. 68-79
-
-
Badgwell, D.B.1
Lu Le, Z.K.2
-
23
-
-
72049088819
-
Growth inhibition of human ovarian cancer cells by blocking STAT3 activation with small interfering RNA
-
Cai L, Zhang G, Tong X, et al. Growth inhibition of human ovarian cancer cells by blocking STAT3 activation with small interfering RNA. Eur J Obstet Gynecol Reprod Biol. 2010;148:73-80.
-
(2010)
Eur J Obstet Gynecol Reprod Biol.
, vol.148
, pp. 73-80
-
-
Cai, L.1
Zhang, G.2
Tong, X.3
-
24
-
-
23044503446
-
A Ras homologue member i directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells
-
Nishimoto A, Yu Y, Lu Z, et al. A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells. Cancer Res. 2005;65:6701-6710.
-
(2005)
Cancer Res.
, vol.65
, pp. 6701-6710
-
-
Nishimoto, A.1
Yu, Y.2
Lu, Z.3
-
25
-
-
57449121645
-
The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells
-
Lu Z, Luo RZ, Lu Y, et al. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J Clin Invest. 2008;118:3917-3929.
-
(2008)
J Clin Invest.
, vol.118
, pp. 3917-3929
-
-
Lu, Z.1
Luo, R.Z.2
Lu, Y.3
-
26
-
-
77951649035
-
The role of autophagy in tumour development and cancer therapy
-
Mathias T, Rosenfeldt KM, et al. The role of autophagy in tumour development and cancer therapy. Expert Rev Mol Med. 2009;11:e36.
-
(2009)
Expert Rev Mol Med.
, vol.11
-
-
Mathias, T.1
Rosenfeldt, K.M.2
|